KLTOW
Klotho Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.09
−9.28%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -81.5%
- EBIT
- -77.4%
- EPS
- -49.8%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2025